Pharmidex attending BioTrinity 2018

April 20, 2018

BioTrinity 2018 will take place over two and a half days from Monday 23rd to Wednesday 25th April.

Pharmidex will be attending this year BioTrinity 2018 conference between the 23-25th of April.

"Our goal for BioTrinity 2018 was simple – to create an ideal network and partnering platform for the global life sciences industry under one roof, ultimately to help shape our healthcare future."

"Our theme for BioTrinity 2018 was 'Next Generation Healthcare' which was explored via a range of insightful keynote and panel discussions including 'AI and Drug Discovery', 'An insight into Nanotechnology', 'Next Generation Chemistry' and 'The Evolution of the Life Science Investment Industry'

We look forward to meeting you at BioTrinity, please pop by and say hello!

< Older Post

Newer Post >

We’re Hiring! Senior/Principal Scientist–In Vivo Pharmacologist

July 30, 2025

We’re Hiring! Senior/Principal Scientist–In Vivo Pharmacologist

🎓 Welcoming Future Scientists to Pharmidex! 🎓

July 28, 2025

We’re delighted to welcome Gabrielle Georgiou and Dr. Mohammed Ahmad from the University of Hertfordshire as they begin their first experience in a scientific CRO environment here at Pharmidex ! This partnership is an exciting step in fostering early-career scientific talent by offering hands-on exposure to real-world drug discovery and preclinical research. A big thank you to the University of Hertfordshire for partnering with us to support the next generation of innovators. We’re proud to play a role in shaping future leaders in science through meaningful, practical learning opportunities. 👩‍🔬 👨‍🔬 Welcome to the team, Gabrielle and Mohammed!

Does your compound taste good enough for the clinic?

July 24, 2025

At Pharmidex , we offer Brief Access Taste Aversion (BATA) testing, which is a behavioural assay that quantifies how test subjects respond to different compounds or formulations by measuring lick response and aversion. This helps identify: ✅ Bitter-tasting APIs ✅ Unpalatable excipients ✅ The success of taste-masking strategies ✅ Formulation-dependent compliance risks Get in touch if you’re developing oral formulations, paediatric drugs, or repurposing bitter APIs, this could be the data your IND package needs.